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Abstract Clinical trials which use imaging typically
require data management and workflow integration
across several parties. We identify opportunities for all
parties involved to realize benefits with a modular
interoperability model based on service-oriented archi-
tecture and grid computing principles. We discuss
middleware products for implementation of this model,
and propose caGrid as an ideal candidate due to its
healthcare focus; free, open source license; and mature
developer tools and support.
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Background
Imaging plays an increasingly important role in the
development of neuropharmacological drugs. 10 out of
106 New Drug Applications (NDAs) approved in the
Division of Neuropharmacological Drug Products at the
Food and Drug Administration (FDA) between 1995 and
2004 had imaging studies (Uppoor et al. 2008). Prominent
examples for imaging used in neuroscience trials are brain
volumetrics for Alzheimers disease, PET imaging of
receptor occupancy, and Gadolinium-enhanced MRI for
Multiple Sclerosis. Service-oriented architecture (SOA) and
grid computing can bring a new level of efficiency to these
clinical imaging trials. While academic studies are often
performed by small, integrated teams, large-scale trials are
characterized by distributed operations and oversight. A
single clinical trial might involve the sponsor, such as a
pharmaceutical or a contrast agent manufacturer; hundreds
of imaging sites; a core lab or contract research organiza-
tion (CRO) tasked with operational control; central radiol-
ogists tasked with data analysis; and a data center for image
archiving. The sponsor alone might comprise several
concerned organizational units, such as separate groups in
charge of image and image-derived data management. Each
of these parties uses its own systems and processes. There
are no widely supported standards which enable, for
example, decentralized data storage and access, study
protocol definition, scanning sequence specification, or
removal of patient-identifying information. Some of these
capabilities are unavailable to imaging trial teams today.
Others are offered by service providers, but are rarely
productized so as to be configurable per trial or client. Even
relatively straight forward workflows can suffer from lack
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quality control. An analysis application could have strin-
gent input image requirements. If data aren’t checked for
compliance soon after acquisition, they may not be usable.
The quality control offering of a CRO is often vaguely
specified, implemented in a closed system, and unavailable
for external queries. SOA is a broadly accepted approach
for modularizing a landscape of such systems into discrete
technical services, each with a public, discoverable inter-
face, and composing those services into applications.
With an SOA framework, there would be further
opportunities for efficiency improvements. For example,
when datasets can be retrieved on demand from an external
organization, each trial party can be considered a remote
data storage resource. Federating access to the pool of these
resources would allow all image transfers to happen as
needed, preventing redundant transmission of bandwidth
hungry datasets. This resource sharing paradigm is known
generically as grid computing. caGrid
1 is an open source
middleware product providing implementations of web
service standards, as well as a set of grid-enabling core
services. By adopting an SOA approach with caGrid,
imaging trial parties can achieve a new level in the
flexibility of their workflow integration, efficiency of their
operations, and quality of their outputs.
Opportunities
Four main roles are involved in a traditional clinical
imaging trial: the company sponsor, the imaging CRO,
the central reader or core labs, and the imaging data
collection sites. Workflows typically span parties in a
standard configuration as depicted in Fig. 1. The sponsor
sets up a high level acquisition guideline with the CRO, and
the sites generate the actual scans, then send the images
back to the CRO. The CRO collates, de-identifies, and
sends the images out to a central reader for analysis, or in
some cases the roles of CRO and reader are taken by a
single academic core lab. The reader sends analysis results
to the sponsor for internal management and use.
In this design, the sponsor sends out a high-level study
protocol definition and receives tables of clinical trial
results. Intermediate research steps essentially occur in a
“closed box” under the purview of the CRO, as depicted in
the figure below.
This closed box workflow is not modular. It is difficult
to include functions from multiple CROs and analysis
service providers in the same trial, and to re-use integration
infrastructure across trials. This can compromise research
quality and result in inefficiencies in the conduct of
imaging trials. Exposing service interfaces to the steps
inside the closed box involves addressing a number of
technology, standards, and regulatory gaps. Specific oppor-
tunities for progress include:
Source Data Management
FDA regulations pertaining to clinical trials source data
management were originally written in reference to a world
of paper documentation, and have areas of ambiguity when it
comes to electronic data. Increasing prevalence of electronic
data in trials has motivated the Electronic Source Data
Interchange (eSDI) Group, an initiative seeking to “investi-
gate the use of electronic technology in the context of existing
regulations for the collection of eSource [electronic source]
data (including that from eDiaries, EHR, EDC) in clinical
trials for regulatory submission” (CDISC 2006). eSDI and
other recommendations do not address certain issues specific
to image data, however, leaving gaps in our understanding of
how best to ensure patient privacy and image readability
while also maintaining source images unchanged.
Data Accessibility
There is no standard image transfer product designed to
connect parties outside their respective intranets. Transfer
from site to CRO by courier on physical media is a typical
practice, causing delays and related QC problems. File
Transfer Protocol (FTP) is sometimes used, but in itself is
not compliant with FDA regulations as described in 21
CFR 11 regarding electronic records; it does not provide a
fault-tolerant transfer mechanism complete with verifica-
tion, user provisioning, and audit trail, nor is it easily
integrated into automated workflows (FDA 1997).
Sponsor access to CRO-managed images is equally
restricted. Inaccessibility to CRO-maintained primary im-
aging data can be a major research impediment. With
images traditionally trapped in data silos at CROs, a
sponsor faces overhead in achieving a number of goals
requiring fast image query and retrieval:
& Provision of data for health authority review
& In-house analysis for methodology development or
validation
& Visual review of images and annotations by CROs and
sponsors (e.g. for consensus reading)
& Provision to secondary analysis services
& Cost efficient archiving
1 This product includes software developed by the Ohio State
University Research Foundation (“OSURF”), Argonne National
Laboratory (“ANL”), SemanticBits LLC (“SemanticBits”), and Eka-
gra Software Technologies Ltd. (“Ekagra”) as described in the license
accessible at the web page http://cagrid.org/display/downloads/caGrid
+1.3+License.
252 Neuroinform (2010) 8:251–259De-identification
A medical imaging data standard, Digital Imaging and
Communications in Medicine (DICOM®),
2 states the need
for image de-identification in its draft Supplement 142: “In
clinical trials, images are often acquired during the course of
clinical care, in which case the patient’s individually
identifiable information needs to be removed to protect the
patient’s privacy. In addition, there is often a need to remove
other information not directly related to the patient’si d e n t i t y
per se, but which might assist in recovering their identity or
bias the image interpretation in some way. Conversely, it is
important to preserve certain specific information for quality
control and analysis that is essential to the conduct of the
clinical trial, which might otherwise be removed.” Imaging
sites may lack tools to perform the de-identification, pushing
the responsibility onto the CROs by necessity. Lacking
standard de-identification profiles, the sites risk removing too
little or too much information.
QC
CROs are often unable to perform real time QC checks.
This commonly occurs when imaging data are sent via
courier. Days pass between the image scan acquisition and
the QC process at the CRO, and if the image data are found
to be unusable, it may be too late for the CRO to ask the
imaging site to correct the errors (e.g. if a re-scan of the
subject is required). Along with improved image transfer,
automated assessment and feedback mechanisms to avert
this scenario are needed.
Furthermore, a lack of standards and tools for describing
and enforcing quality requirements often limits sponsors
from conducting in-house or secondary analyses. Newly
available, highly automated analysis algorithms can have
stringent requirements on input image quality. These are
difficult to enforce solely by contract if the CRO performing
QC is not also responsible for all aspects of the analysis.
Analysis
Specialized analysis services are often available only from
third parties who do not also provide trial operational
support. For example, a sponsor might need to employ a
proprietary image analysis service offered by a specific
provider, and also a CRO to manage the trial operations and
the analysis workflow. In this case, developing and
validating interfaces to integrate the analysis service into
the CRO workflow could cause months of delay for a one-
off solution which could be useless in the context of other
trials.
This section has begun to demonstrate some of the
opportunities for information technology to enhance imag-
ing trial workflow. The next section will discuss specific
implementation recommendations.
Recommendations
Software applications for clinical imaging trials should
become service-oriented. The benefit of composable,
reusable services to all parties is ease of integration. Sites
benefit from a faster, more user-friendly process for
submitting images to a clinical trial; CROs gain a wider
market for their services by selling them for use in trials
they aren’t otherwise supporting; software providers simi-
larly can sell their products as plug-ins for trial workflows;
and sponsors enjoy flexibility in mixing and matching
services from different parties. Using a grid computing
approach to optimize data sharing further minimizes time
2 DICOM
® is the registered trademark of the National Electrical
Manufacturers Association for its standards publications relating to
digital communications of medical information.
Fig. 1 Standard workflow for a
clinical trial using imaging
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between all parties.
Specific benefits can be realized in several areas:
Mix and Match Workflows
Taking full advantage of widespread SOA adoption, a
sponsor should be able to freely mix and match the
following services from CROs, manufacturers, and soft-
ware companies:
– operations (site initiation and management, monitoring)
– scan acquisition definition
– image de-identification and transfer
– image tracking
– image QC (on-site or central)
– analysis/processing
– reporting
– image viewing (both remotely or locally)
– long-term image archiving
By freely composing these into workflows, a sponsor
may support significantly more complex scenarios, such as:
Imaging based central safety read:
Fast image transport would be possible between all
study partners. This would enable real time QC and
fast reads, necessary in a variety of scenarios, e.g.
when safety signals are read by a secondary service
provider.
Small exploratory study involving post-processing
activity without an imaging CRO:
Direct transfer of images to the sponsor’si m a g e
management system would be possible with minimal
human intervention once challenges of sufficient de-
identification, correct data formatting, correct associa-
tion of study metadata with images (i.e. subject
identifier, time point description, etc.) and reliable
transfer are addressed. In-house processing capabilities
could then be leveraged, provided that such use is
specifically described in the study protocol and the
signed patient Informed Consent (IC).
3
Central reader use of third party applications:
In a single trial, an analysis service provider would
analyze images by using a specialized third party
application owned by the sponsor or a software
provider without undertaking expensive integration
efforts.
Harmonized image normalization across studies:
Different studies would use different analysis providers
but share the same pre-processing pipelines for image
normalization.
Figure 2 demonstrates the flexibility of SOA based
workflows by comparison to the process depicted in Fig. 1.
Source Data Management
The eSDI provides broadly accepted recommendations for
managing electronic source data. We want to apply these to
imaging scenarios. In contrast with most electronic clinical
data, images are produced in the structurally complex
DICOM® format. The use of DICOM® gives rise to three
issues:
1) Messaging protocol: DICOM® defines a messaging
protocol as well as a file format. Images can be
encapsulated by messages, and the content of these
messages includes encoding and messaging specific
information which is not relevant to understanding the
image itself, and which is dependent on the implemen-
tation context of the supporting software. When
DICOM® images are transmitted using these messages,
it is impossible to confirm that they remain unchanged in
accordance with the relevant regulations (ICH 1996).
2) Structural complexity: The 2008 version of the
DICOM® standard is over 3600 pages long with
additional supplements and corrections added since
publication. The format is so complex and flexible that
different implementations often produce images with
structurally non-conforming aspects. These images
need to be “cleaned” so that they flawlessly conform
to the DICOM® standard, or else they may be
unreadable and unusable in the clinical trial.
3) De-identification of images to meet trial require-
ments: Images collected for clinical trials are also part
of the general care workflow of hospitals. As such,
DICOM® images potentially contain hundreds of
different items (e.g. patient names and addresses) that
must be removed before they meet clinical trial de-
identification requirements set forth by HIPAA and
corresponding European regulations.
A site image submission service compatible with source
data regulations must be able to provide solutions for those
three issues.
Issue 1 may be resolved by using the DICOM® file
format exclusively in order to “freeze” an image into a
persistent byte-stream whose contents are static, and which
can be copied across systems and remain unchanged.
To resolve issues 2 and 3, we reference the fourth eSDI
scenario, “Extraction and Investigator Verification (Electronic
3 The IC cannot simply allow for image use in unspecified or
unknown contexts (ICH 1996).
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workflow. Since the DICOM® images are not initially
compatible with clinical trial protocol requirements, and the
scanner itself as a medical device does not fall under the
computerized system validation requirements in 21 CFR 11,
the original images can be viewed as being part of an
electronic health record (EHR) environment rather than a
clinical trial electronic data capture (EDC) system. They may
becleanedandde-identifiedtoremedyissues2and3,verified
by the investigator, e.g. with electronicsignature, and are only
thereafter considered source data (CDISC 2006)( F i g .3).
Sites frequently lack the proper tools to enact this
workflow, providing sponsors and CROs a clear opportu-
nity to enable a means of optimal regulatory compliance by
using site submission tools meeting the following require-
ments: 1) image cleaning and de-identification, 2) means
for the investigator to be able to verify the source data, 3)
image copy from hospital site to target in a persisting
format, and 4) persistence of a local copy, or access
provision to an online copy.
Data Accessibility
Partners who need to exchange imaging data can provide or
consume image transfer services, which will depend on the
XML definition of clinical trial image collections. For
Fig. 2 Potential data flow and
distribution of services in an
SOA enabled workflow
Fig. 3 “The fourth eSDI sce-
nario for extraction of data from
electronic health records with
verification by the investigator”
(CDISC 2006)
Neuroinform (2010) 8:251–259 255example, a CRO and a sponsor might each deploy “Submit
Image Object” and “Retrieve Image Object” services built on
top of the caGrid platform (which provides a means of
transmitting the binary image data as well as implementing
service interfaces); sites and analysis service providers could
connect to these using standard image submission clients.
Storage and bandwidth capacity at a sponsor with many
imaging trials may be too limited to allow collection and
retention of all images for all trials. SOA enables convenient
access todistributed archivesof imagesat CROs,using image
query and transmission services for retrieval as needed.
De-identification
Achieving better control of de-identification at both CROs
and imaging sites is largely a matter of providing standards
and tools. Standardizing on DICOM® for image representa-
tion gives a frame of reference against which de-identification
requirements can be defined. The standard requirements
themselves must still be defined, and there must be flexible
mechanisms for enforcing them. DICOM® Working Group
18 has produced a draft supplement to the DICOM® standard
providing a number of confidentiality profiles for this
purpose. An XML format can be used to provide a machine
readable specification of the standard profiles, and also case-
specific customizations, e.g. the retention of a private tag
which contains coil information necessary for image contrast
quantification. This definition can be shared, and the sponsor
and other partners can build supporting tools for use at
hospital sites.
Sometimes identifying information is “burned into” the
actual image, meaning that part of the image itself is
overwritten with a patient identifier. This is more difficult
to automatically correct like the metadata, but can be
checked during QC, as described below.
QC
More generalized QC requirements can be described with
XML in the same way as de-identification rules. A patient
name field may be slotted for removal, but an acquisition
date field may be flagged as requiring content, or an “echo
time” field for MRI data may be required to have a specific
value range. DICOM® compliance and image compatibility
with processing software can be improved significantly by
enforcing such rules.
Using a standard QC profile and a data exchange service, a
CRO can implement real-time QC procedures. A completely
automated workflow may be defined to receive images
through a web accessible service, apply a QC profile upon
receipt and even check for image acquisition quality issues
such as artifacts, and accept or reject the submission with
appropriate notification back to the sender. A process that
previously took days is reduced to minutes, and sites can
receive feedback soon enough to take remedial action if
needed, e.g. a patient re-scan. Additionally, the site itself can
take on the QC burden using a supporting toolset.
Some QC measures can be performed on the image
bitmap itself, such as checking for burned in identifying
information, evaluating the contrast, or checking that the
correct anatomy has been imaged. These can be integrated
into the workflow in much the same way as analysis
algorithms, as described below.
Analysis
With SOA, analysis tools can be wrapped in public
interfaces, making them discrete and re-usable components
of the trial workflow just like other services. Still, analysis
tools have widely varying semantics in terms of what inputs
they require (a single image, two separate images acquired
with different scanning sequences, images combined with
specific clinical data, etc.) and what outputs they produce.
Harmonizing and ultimately standardizing the semantics of
analysis algorithm interfaces is a necessary effort above and
beyond SOA.
Implementation
An SOA depends on services, and their interoperability
depends on common syntax and semantics. A growing
number of providers have already begun to offer compo-
nentized solutions. For example, image analysis algorithms
can be packaged and sold as fully automated applications.
So far, however, the providers have been given neither
incentive nor technology standards for building service
interfaces to their tools. Sponsors can drive the adoption of
SOA for imaging trials by defining messaging and data
standards, deploying their own applications as services, and
incentivizing their adoption through open source applica-
tion development and contractual stipulations.
DICOM® comprises an imaging specific messaging
protocol that supports many radiology department workflows,
such as image transfer from scanner to picture archiving and
communication system (PACS), image querying, printing,
hanging protocol, graphical annotations, teaching files, and
image based reporting. However, these capabilities were
developed for use between local radiology sites via secure
hospital LANs. DICOM® is ill equipped as a messaging and
image transfer protocol over the Internet due to lack of
security,faulttolerance,discoverability,andadaptability;from
a regulatory perspective, it’s problematic for clinical trial
workflows simply because noestablishedaudit trail can verify
imagepreservation.XMLbasedspecifications,suchasSimple
Object Access Protocol (SOAP), do not suffer from these
256 Neuroinform (2010) 8:251–259drawbacks. They are widely supported as service messaging
standards due to flexibility and broad tool support. They form
the backbone of a group of standards known collectively as
web services, which are widely implemented in the SOA
solution space.
The messaging standards define a syntax for interoperabil-
ity, but a semantic model for describing the data is also
needed.Thisisapre-requisiteforsharingqualityrequirements
and correctly performing image reads. While DICOM® is
unsuitableinthiscaseasamessagingprotocol,itdoesprovide
a widely supported image file format and semantic model.
Presently most imaging devices can output in DICOM®,
makingitanidealchoiceforsourcedatacapture.Downstream
analysis applications often require other formats, such as
NIfTI-1.1
4 (a specification designed to facilitate file-based
interoperability between functional MRI analysis tools) or
Nrrd (a file format and toolset for representing and
processing multi-dimensional image data),
5 but in such
cases a conversion has to be performed regardless, and
many tools exist for the purpose. Maintaining the original
image data in their DICOM® file format is a simple
approach which allows for maximum flexibility. Beyond
the images, additional trial metadata must be described, to
define both the interrelationships of image files (i.e. which
DICOM® image instances or DICOM® series comprise a
discrete unit of input for downstream analysis) and the
associations to trial time points, subject identifiers, etc.
These may be thought of as “metadata” in a DICOM® and
imaging world, but they are integral to the primary data in
clinical trials. They need to be managed in databases and
transmitted via standard database integration techniques.
XML is again the de facto web services standard format for
serializing database objects.
With interoperability standards defined, the next step is
implementing and deploying services. The software infra-
structure enabling interactions between these services is
known generically as “middleware.” Web services middle-
ware comprises implementations of standards such as SOAP.
A clinical imaging trial SOA requires a middleware that
supports partners with widely varying IT proficiency and
budget; provides out of the box support for web service
standards for messaging, security, and binary data transport;
enjoys widespread adoption; and complies with relevant
healthcare standards. caGrid fully satisfies these requirements,
supporting “the requirements associated with discovery,
analysis and integration of large scale data, and coordinated
studies [in] biomedical fields” (Oster et al. 2008). It was
developed as the software infrastructure underlying the
cancer Biomedical Informatics Grid® (caBIG®), an initiative
of the National Cancer Institute to enable sharing of data and
research tools across institutions (Oster et al. 2008). Its
particular advantages include: 1) a robust and consistent
platform dedicated to service implementation, 2) an open
source license and free support resources that can be used by
all partners, including small partners unable to employ more
expensive middleware, 3) a library of existing services
specific to healthcare and resource sharing, 4) a strong
reception and increasing adoption by the biomedical research
communities, and 5) coherence with all important standard-
ization initiatives (HL7, DICOM®, CDISC). A substantial
technical overview as well as information about its utilization
by the healthcare community may be found at the caGrid
website.
6 As an example of a specific implementation for real
world studies, the CardioVascular Research Grid (CVRG) is
linked with eight driving biomedical projects as described on
its project website.
7
Competing commercial middleware, such as TIBCO’s
offerings, Oracle Fusion Middleware, or IBM WebSphere
are expensive products with no special healthcare focus. Free
andopensourcemiddlewareisavailable,suchasApacheAxis
for SOAP, but again lacks a healthcare focus, as well as the
toolkits and support resources of the commercial products.
caGrid strikes a balance between these. It is open source, free,
and also provides commercial-grade developer support with
features such as a service development GUI. It is built on top
of other free middleware such as Axis, providing additional,
not competing, features. Mature products built with it are
already available, such as the In Vivo Imaging Middleware
(IVIM).Thesetooareopensource,offeringasignificantvalue
addition for new service development with overlapping
requirements.
Other resource sharing and interoperability initiatives
exist, but none whose goals are so well aligned with the
infrastructure needs of clinical trials with imaging end-
points, in particular the provision and marketing of a
service oriented middleware. For example, the Biomedical
Informatics Research Network (BIRN) is a collaborative
effort between several research institutions to provide data-
sharing infrastructure. It offers a grid of shared data and
analytical resources, but lacks a service-oriented architec-
ture and a middleware product. Integrating the Healthcare
Enterprise (IHE) is an organization focused on issuing
standards-based specifications of healthcare tasks which
can be implemented to achieve interoperability between
systems. It provides a number of profiles for common
healthcare use cases. Of particular interest is its Cross
Enterprise Document Sharing for Imaging (XDS-I.b) Inte-






Neuroinform (2010) 8:251–259 257transactions, in terms of web service standards, which can be
implemented to enable the kind of on demand, distributed
image storage and retrieval available with a caGrid enabled
SOA. XDS-I.b provides concrete, tested specifications, but
no implementations, middleware, or tools. Also, it satisfies
just one use case of several for imaging trial enhancement.
caGrid provides a complete implementation middleware with
all the underlying messaging, image transfer, and security
mechanisms necessary to tie services from different partners
together into trial workflows. As an open source framework,
caGrid does not include the same level of customer support
and comprehensive documentation as some commercial
alternatives, resulting in a steeper learning curve for adopters.
On the other hand, innovators can help flatten this curve with
their own open source, caGrid-enabled reference tools.
Novartis has done this with the release of ImagEDC,
8 an
image de-identification, cleaning, and submission software.
It consists of a client tool which can be deployed at hospital
sites, enabling them to produce images compatible with
trial requirements without additional processing required
from the CRO; a “Submit Image Object” web service which
consumes trial data and images, storing them in a local
repository; and a tracking service which records workflow
events such as image submission and receipt. The client is
designed with the aforementioned eSDI scenario in mind.
The inputs may be considered EHR data, and the outputs
include local and remote DICOM image files, plus an
electronic record of the operator’s user name, which can be
used to signify verification that they constitute the source
data for a clinical trial. The service is defined using web
service standards, and built using caGrid. The client or the
service business logic can be re-used as they are, or re-
implemented according to the needs of a specific organiza-
tion or trial, without changing the service definition. For
example, ImagEDC could be deployed to connect a CRO
and a sponsor. The reference “Submit Image Object”
operation could be used to transfer the image files
immediately to the sponsor, or another implementation
could be written which would only transmit the identifiers.
The sponsor could use these to track image availability at
the CRO, and issue queries to retrieve the image data on-
demand. The site could use the reference implementation of
the client tool in either case.
ImagEDC demonstrates the benefits that movingtoward an
SOA can bring to clinical imaging trials. Fully realizing this
goal would require the implementation of a broad range of
services. ImagEDC is a single example covering the “Submit
Image Object” scenario. As a proof of concept, it also shows
the suitability of caGrid as a service middleware that doesn’t
require extensive ITresources for implementation. At the time
of this article’s publication, ImagEDC is the product of two to
four weeks full time equivalent (FTE) development effort,
with a heavy reliance on caGrid, but no prior expertise with it.
Substantial organizational challenges involved in imple-
menting an SOA across different partners remain, but these
are present for any infrastructure integration efforts.
Sponsors can address them with contractual obligations
for CROs; with sites, it is less straight forward, since they
do not typically have infrastructure and IT resources to
implement custom integrations or complicated deploy-
ments. This can be addressed by providing them with tools
with minimum barriers to adoption. For example,
ImagEDC uses Java Web Start technology to allow a user
to download, install, and run the tool on his or her local
machine simple by visiting a URL in a web browser.
Conclusion
There is opportunity to enhance the conduct of imaging trials
through SOA and grid computing approaches. Improved
interoperability brings clear benefits to trial sponsors in terms
of flexibility, efficiency, and quality. Service providers also
gain a wider market for their products, and everyone benefits
from lighter integration efforts.
While there is much useful work being done already on
healthcare interoperability standards such as IHE’s XDS-I.
b, CROs and sponsors have yet to implement these as part
of a service-oriented framework optimized for resource
sharing. The missing ingredient is middleware. caGrid
neatly fills this gap, providing not only a web services
stack, but a rich set of core services and developer tools.
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